Required

Clinical Trial Underway For Potential New Treatment Option For Patients With Mesothelioma

Mesothelioma is a rare cancer with about 3,000 new cases in the United States each year. With limited treatment options, it is nearly always fatal. Mesothelioma is so hard to treat because it typically does not grow as a single tumor, but rather spreads along to other tissue, nerves, and blood vessels. As such, surgery and/or radiation are often ineffective options. Since 2004, only two therapies have been approved for mesothelioma patients.

However, researchers at the University of Vermont Cancer Center and Wake Forest Medical School have identified a new therapeutic approach that is causing considerable optimism. Researchers discovered that tumor cells produce a lot of waste and that the cells must dispose of or it can become toxic to the tumor and kill it. The new drug is designed to inhibit a tumor cell’s ability to manage its toxic waste. Researchers noted that it is basically “like putting a potato into the tailpipe. The tumor cells choke on their own exhaust.” While the research has been centered around mesothelioma, there is considerable data to suggest the therapy could work on other cancers as well.

Clinical trials are underway throughout the United Kingdom and may move to the U.S. in 2022. Exposure to asbestos causes almost all mesothelioma cases. Mesothelioma often develops decades after asbestos exposure occurs because it takes time for asbestos fibers to cause the damage that leads to cancer. If you have been diagnosed with mesothelioma or asbestosis, you may have the right to recover compensation that can help you and your family. Contact us to see if we can help with your case.

Charles E. Boyk Law Offices, LLC